Daiichi revealed on Friday it expects to post an “extraordinary” loss of 149.4 billion Japanese yen, or around $950 million. It is cutting its operating profit forecast by 106 billion Japanese yen ($677 million) for the fiscal year ending March 31.
Daiichi Sankyo is scrapping plans to build antibody-drug conjugate manufacturing capacity and recorded an “extraordinary loss” of 149.4 billion Japanese yen ($950 million) after overpromising …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
With a new CEO prepared to take the reins next month and three key launches on deck for 2026 and 2027, Takeda is ready to shake…
Bristol Myers Squibb and Hengrui Pharma signed a massive deal worth up to $15.2 billion. Takeda aims to cut 4,500 jobs in fiscal…
Nissan stima una perdita operativa di 275 miliardi di yen, equivalente e 1,54 miliardi di euro per l'anno fiscale in corso, a…
Nissan stima una perdita operativa di 275 miliardi di yen, equivalente e 1,54 miliardi di euro per l'anno fiscale in corso, a…
Honda says it racked up a full-year loss for the first time ever, losing $2.7 billion in the last fiscal year due to a costly…
La giapponese Nissan Motor prevede di chiudere l'anno fiscale 2025 (concluso il 31 marzo 2026) con una perdita limitata a 550…
